Hanseníase virchowiana associada ao uso de inibidor do fator de necrose tumoral α: relato de caso

Hanseníase virchowiana associada ao uso de inibidor do fator de necrose tumoral α: relato de caso

A terapia anti-TNFα tem sido amplamente utilizada em diversas artropatias inflamatórias crônicas, em especial artrite reumatoide (AR). No entanto, há preocupações quanto à segurança e ao risco de doenças infecciosas nos pacientes. O objetivo deste artigo é descrever um caso de hanseníase, forma virc...

Full description

Bibliographic Details
Main Authors:	Daniele S Freitas, Natalia Machado, Fernando V Andrigueti, Edgard T Reis Neto, Marcelo M Pinheiro
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Reumatologia
Series:	Revista Brasileira de Reumatologia
Subjects:	TNF blockers rheumatoid arthritis adverse events leprosy
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042010000300013&lng=en&tlng=en

Similar Items

Hanseníase virchowiana associada ao uso de inibidor do fator de necrose tumoral α: relato de caso Lepromatous leprosy associated with the use of anti-TNF α therapy: case report
by: Daniele S Freitas, et al.
Published: (2010-06-01)

HANSENÍASE NO CURSO DE TERAPIA IMUNOBIOLÓGICA NA ARTRITE REUMATOIDE: RELATO DE CASO
by: Vitor Alves Cruz, et al.
Published: (2015-12-01)

The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis
by: Natalia P. Machado, et al.
Published: (2013-09-01)

Hanseníase borderline virchowiana Borderline lepromatous leprosy
by: Christiane Matsuo, et al.
Published: (2010-12-01)

Necrose de canto medial associado a hanseníase virchowiana: relato de caso
by: Leiser Franco, et al.
Published: (2010-12-01)

Periodontal Conditions during Arthritis Therapy with TNF-α Blockers
by: Rudolf Schiefelbein, et al.
Published: (2018-10-01)

UVB suscetibilidade como fator de risco para o desenvolvimento da hanseníase virchowiana UVB susceptibility as a risk factor to the development of lepromatous leprosy
by: Mecciene Mendes Rodrigues, et al.
Published: (2010-12-01)

Deletion at 2q14.3 is associated with worse response to TNF-α blockers in patients with rheumatoid arthritis
by: Ki-Nam Gu, et al.
Published: (2019-08-01)

Seronegative Bilateral Symmetrical Inflammatory Polyarthritis: Think Twice Before Starting Immunosuppression
by: Omar Alsaed, et al.
Published: (2018-06-01)

Comparative efficacy and safety of chimeric and recombinant anti-TNF-α mAbs
by: V. N. Drozdov, et al.
Published: (2021-05-01)

Rheumatoid Arthritis Saudi Database (RASD): Disease Characteristics and Remission Rates in a Tertiary Care Center
by: Almoallim H, et al.
Published: (2020-08-01)

Adalimumab Induced Systemic Lupus Erythematosus
by: Songül Çildağ, et al.
Published: (2012-03-01)

HTLV-1 associated myelopathy diagnosed during lepromatous leprosy reaction treatment: a case report Mielopatia associada ao HTLV-1 diagnosticada durante tratamento de hanseníase virchowiana reacional: relato de caso
by: Marcelo Grossi Araújo, et al.
Published: (2010-08-01)

Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs
by: M. Vomero, et al.
Published: (2019-01-01)

O papel dos inibidores do fator de necrose tumoral no tratamento da artrite idiopática juvenil The role of tumor necrosis factor inhibitors in the treatment of juvenile idiopathic arthritis
by: Patrícia Martin, et al.
Published: (2006-04-01)

O envolvimento do proteossomo na perda muscular de modelo de artrite induzida por colágeno e o efeito do tratamento com inibidor do fator de necrose tumoral
by: Teixeira, Vivian de Oliveira Nunes
Published: (2016)

O envolvimento do proteossomo na perda muscular de modelo de artrite induzida por colágeno e o efeito do tratamento com inibidor do fator de necrose tumoral
by: Teixeira, Vivian de Oliveira Nunes
Published: (2016)

O envolvimento do proteossomo na perda muscular de modelo de artrite induzida por colágeno e o efeito do tratamento com inibidor do fator de necrose tumoral
by: Teixeira, Vivian de Oliveira Nunes
Published: (2016)

AvaliaÃÃo comparativa do uso prÃ ou pÃs-operatÃrio de amoxicilina em exodontias simples realizadas em pacientes portadores de artrite reumatoide tratados com inibidores de fator de necrose tumoral alfa e/ou metotrexato
by: Ana Laryssa Ferreira Gomes Porto
Published: (2015)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
by: S.L.E. Ribeiro, et al.
Published: (2008-11-01)

Therapeutic effects of Rheumatoid Arthritis on Aspergillosis development
by: Ali AL-Janabi
Published: (2020-03-01)

A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis
by: Hisashi Yamanaka, et al.
Published: (2019-12-01)

Association of TNF-alpha polymorphism (-308 A/G) with high activity of rheumatoid arthritis and therapy response to etanercept
by: Marinković Milena, et al.
Published: (2011-01-01)

Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis
by: A. S. Kolbin, et al.
Published: (2020-05-01)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
by: Olivera Boskovic, et al.
Published: (2020-01-01)

Study on Tumor Necrosis Factor-α· Gene Polymorphism in Rheumatoid Arthritis
by: Kim Kyung-Un, et al.
Published: (2007-06-01)

Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
by: Yen-Ju Lin, et al.
Published: (2020-04-01)

Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis
by: Josef S. Smolen, et al.
Published: (2020-08-01)

Action of anti-TNF-α drugs on the progression of Alzheimer's disease: A case report
by: Carlos Henrique Ferreira Camargo, et al.

Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity
by: Mones M. Abu Shady, et al.
Published: (2015-07-01)

Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
by: Jean-Luc Davignon, et al.
Published: (2018-10-01)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01)

Hanseníase associada a granuloma elastolítico Leprosy combined with elastolytic granuloma
by: Aryon de Almeida Barbosa Jr, et al.
Published: (2002-10-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
by: Takacs P, et al.
Published: (2019-01-01)

Methotrexate Enhances Apoptosis of Transmembrane TNF-Expressing Cells Treated With Anti-TNF Agents
by: Qiaolei Wang, et al.
Published: (2020-08-01)

Abordagem diagnóstica da tuberculose latente na artrite reumatóide Latent tuberculosis diagnosis in rheumatoid arthritis
by: Cláudia Diniz Lopes Marques, et al.
Published: (2007-12-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
by: Emna Hannech, et al.
Published: (2021-06-01)

Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
by: George W. Reed, et al.
Published: (2019-11-01)

Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients
by: Jesus Castillo-Hernandez, et al.

In Human Autoimmunity, a Substantial Component of the B Cell Repertoire Consists of Polyclonal, Barely Mutated IgG+ve B Cells
by: Graeme J. M. Cowan, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_ch11s95agfclclgrbeq93ojnqk